Stock Earnings
IMNM (Immunome Inc) may reap gains as insiders became active recently
Immunome Inc’s recent filing unveils that its Director BIENAIME JEAN JACQUES acquired Company’s shares for reported $46900.0 on Jun 03
Menu
Immunome Inc’s recent filing unveils that its Director BIENAIME JEAN JACQUES acquired Company’s shares for reported $46900.0 on Jun 03
Immunome Inc’s filing revealed that its Director BIENAIME JEAN JACQUES acquired Company’s shares for reported $46900.0 on Jun 03 ’25.
In a filing, Immunome Inc revealed its Director BIENAIME JEAN JACQUES acquired Company’s shares for reported $46900.0 on Jun 03
Immunome Inc’s recently made public that its Director BIENAIME JEAN JACQUES acquired Company’s shares for reported $46900.0 on Jun 03
Immunome Inc’s filing revealed that its Director BIENAIME JEAN JACQUES acquired Company’s shares for reported $46900.0 on Jun 03 ’25.
Immunome Inc’s recently made public that its Director BIENAIME JEAN JACQUES acquired Company’s shares for reported $46900.0 on Jun 03
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Immunome Inc’s recent filing unveils that its Director BIENAIME JEAN JACQUES acquired Company’s shares for reported $46900.0 on Jun 03
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
In a filing, Immunome Inc revealed its Director BIENAIME JEAN JACQUES acquired Company’s shares for reported $46900.0 on Jun 03